Revenue: The sum of all revenue fields included for a company's operating activities.
Karyopharm Therapeutics Inc. (KPTI) had Revenue of $44.04M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$44.04M |
$-33.13M |
|
$2.11M |
|
$41.93M |
|
$59.26M |
|
$-15.22M |
|
$-17.87M |
|
$-33.09M |
|
$-33.09M |
|
$-33.13M |
|
$-33.13M |
|
$-33.13M |
|
$-33.13M |
|
$-15.22M |
|
$-12.34M |
|
8.67M |
|
8.67M |
|
$-3.82 |
|
$-3.82 |
|
| Balance Sheet Financials | |
$89.75M |
|
$0.12M |
|
$6.49M |
|
$96.23M |
|
$87.16M |
|
$176.74M |
|
$278.33M |
|
$365.49M |
|
$-269.26M |
|
$-269.26M |
|
$-269.26M |
|
8.70M |
|
| Cash Flow Statement Financials | |
$-63.54M |
|
$38.38M |
|
$0.36M |
|
$62.81M |
|
$38.02M |
|
$-24.79M |
|
$10.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
-1.91 |
|
-0.70 |
|
95.20% |
|
-34.56% |
|
-34.56% |
|
-- |
|
-75.14% |
|
-75.21% |
|
$-63.54M |
|
-- |
|
-- |
|
-- |
|
0.46 |
|
0.53 |
|
1.38 |
|
65.14 |
|
12.30% |
|
12.30% |
|
-34.42% |
|
35.81% |
|
$-30.94 |
|
$-7.33 |
|
$-7.33 |
|